文献速递肾小球疾病遗传性与小管间质肾病慢性肾脏病

甘氨酸替换外显子位置影响常染色体显性Alport综合征肾脏生存

Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome.
PubMed 文献 · Nephrol Dial Transplant · 2025-01-01

本研究为多中心回顾性研究,纳入97例携带COL4A3或COL4A4单致病性变异的患者,随访期间终末期肾病(ESKD)患病率为28.7%(中位年龄47.5岁)。在60例胶原域甘氨酸替换患者中,突变位于远端外显子与更差的肾脏生存及eGFR下降更显著相关,而严重突变(移码、终止获得、大片段缺失、影响剪接)未影响肾脏生存。

要点

  • 常染色体显性Alport综合征(ADAS)可进展至ESKD,随访ESKD患病率28.7%。
  • 甘氨酸替换位于远端外显子者肾脏生存更差,eGFR下降更显著。
  • 严重突变(移码、终止获得、大片段缺失、影响剪接)未影响肾脏生存。

核心结论

  • ADAS可导致ESKD,甘氨酸替换累及远端外显子对肾脏生存有负面影响,可能源于三聚化缺陷。

研究设计与样本

  • 多中心回顾性研究,纳入97例携带COL4A3或COL4A4单致病性变异的患者。

主要发现

  • 随访期间ESKD患病率为28.7%,中位年龄47.5岁(四分位距39.1-55.8)。
  • 23例携带严重突变(移码、终止获得、大片段缺失、影响剪接),60例携带胶原域甘氨酸替换。
  • 甘氨酸错义变异位于远端外显子者肾脏生存更差,eGFR下降更显著。
  • 严重突变的存在未影响肾脏生存。

临床怎么用

  • 对ADAS甘氨酸替换患者可依据突变外显子位置(远端 vs 近端)进行个体化随访。
  • 甘氨酸替换外显子位置有望纳入未来预后评分以准确预测肾脏结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unlike X-linked or autosomal recessive Alport syndrome, no clear genotype/phenotype correlation has yet been demonstrated in patients carrying a single variant of COL4A3 or COL4A4. METHODS: We carried out a multicentre retrospective study to assess the risk factors involved in renal survival in patients presenting a single pathogenic variant on COL4A3 or COL4A4. RESULTS: A total of 97 patients presenting a single pathogenic variant of COL4A3 or COL4A4 were included. The prevalence of end-stage kidney disease (ESKD) during follow-up was 28.7% [median age 47.5 years (interquartile range 39.1-55.8). A total of 23 patients carried a 'severe' mutation (frameshift, stop gain, extensive deletion, impacting splicing) and 60 patients presented a glycine substitution in a collagenous domain. In patients with glycine missense variants, the location of the mutation in the distal exons was associated with worse renal survival with a more pronounced decline in the estimated glomerular filtration rate compared with variants in proximal exons. Conversely, the presence of a severe mutation did not impact renal survival. CONCLUSION: Our results confirm that autosomal dominant Alport syndrome (ADAS) can lead to ESKD. We demonstrated that a glycine substitution involving the distal exons had a negative impact on renal survival in ADAS patients, probably due to a trimerization defect. This could help improve personalized follow-up in ADAS patients with glycine substitution and could be integrated into a future prognostic score to accurately predict renal outcomes.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Pagniez MS, Fages V, Gatinois C, et al. Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. Nephrol Dial Transplant. 2025. PMID: 39810285. doi:10.1093/ndt/gfaf011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。